Financials of Lincoln Pharmaceuticals Ltd
Financial Report - LINCOLN PHARMACEUTICALS LTD
Here is a summary of financial information of LINCOLN PHARMACEUTICALS LTD for the financial year ending on 31 March, 2021.- Revenue / turnover of LINCOLN PHARMACEUTICALS LTD is INR 100 cr - 500 cr
- Net worth of the company has increased by 19.86 %
- EBITDA of the company has increased by 37.03 %
- Total assets of the company has increased by 19.47 %
- Liabilities of the company has increased by 19.06 %
Successfully added to cart.
Operating Revenue | INR 100 cr - 500 cr |
EBITDA | 37.03 % |
Networth | 19.86 % |
Debt/Equity Ratio | 0.00 |
Return on Equity | 16.55 % |
Total Assets | 19.47 % |
Fixed Assets | 0.19 % |
Current Assets | 28.02 % |
Current Liabilities | 19.06 % |
Trade Receivables | 12.35 % |
Trade Payables | 19.24 % |
Current Ratio | 4.17 |
* Company has reported to have approved financials for 31 March, 2022. However, in case, they are not available at MCA because of non-filing or damage, then we will provide the latest financials downloadable from MCA.
How to get financials of LINCOLN PHARMACEUTICALS LTD in Company360
Tofler Company360 provides access to any Indian company's financial documents, charts, ratio analysis and more. It lets you compare financials of several companies and study performance trends. These financials can also be downloaded in excel format. Here is the video showing how you can study the financials of an Indian company on the Company360 platform.
Company360 plans

Know more about your vendors, clients and competitors.
Financials, scores, ratios, excels, reports and more.
@ INR 9000/quarter
Join our newsletter
5 Biggest Charges
GROUP STRUCTURE - LINCOLN PHARMACEUTICALS LTD
Available in purchased financial report
Successfully added to cart.
FAQ - LINCOLN PHARMACEUTICALS LTD
-
What details can I find in the financial reports of LINCOLN PHARMACEUTICALS LTD?
The financial reports of LINCOLN PHARMACEUTICALS LTD include financial history (previous 5 Years), ratio analysis, management details such as directors & key persons of the company, shareholding & group structure details, mortgages & charges on LINCOLN PHARMACEUTICALS LTD.
-
What is the Operating Revenue of LINCOLN PHARMACEUTICALS LTD?
The operating revenue of LINCOLN PHARMACEUTICALS LTD is in the range of INR 100 cr - 500 cr for the financial year ending on 31 March, 2021.
-
What is the increase in EBITDA of LINCOLN PHARMACEUTICALS LTD since last year?
The EBITDA of LINCOLN PHARMACEUTICALS LTD has increased by 37.03 % over the previous year. At the same time, it's book networth has increased by 19.86 % for the financial year ending 31 March, 2021.
-
What is the price of financial reports of LINCOLN PHARMACEUTICALS LTD?
The price of financial report of LINCOLN PHARMACEUTICALS LTD prepared by Tofler is INR 799. It is an easy-to-read PDF report on the company that includes five year financial information, ratio analysis, management, group structure, shareholding pattern and more.
Subscribe to the Tofler Company360 program for complete access to Tofler's database. -
How to check Financial Reports of LINCOLN PHARMACEUTICALS LTD?
Follow 5 easy steps to download the balance sheet of LINCOLN PHARMACEUTICALS LTD:
1) Search for the company you require in the Tofler search bar
2) Select the financial reports in the Company Financials Section and add them to the cart
3) Confirm your email address on which you want reports to be delivered
4) Confirm & Checkout to Pay
5) Reports will be sent to your registered email address
Company360 plans

Know more about your vendors, clients and competitors.
Financials, scores, ratios, excels, reports and more.
@ INR 9000/quarter
Join our newsletter
Send e-mail
LINCOLN PHARMACEUTICALS LTD
Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to their respective owners. Read More